PARIS, June 13 — French drug maker Sanofi said today a Covid booster shot it is developing with Britain’s GlaxoSmithKline has produced positive results against Omicron and other variants in clinical trials.
The results are a boost for Sanofi and GSK, which have lagged behind rivals in offering a Covid vaccine. It also generated a “higher immune response” than the Pfizer-BioNTech booster shot, the French company said. “Covid-19 keeps evolving and the combination of emergence of variants and waning immunity is likely to lead to the need for additional booster shots, at least in some populations,” said Sanofi Vaccines executive vice president Thomas Triomphe.
Malaysia Latest News, Malaysia Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.